Market Scope expects intraocular lens (IOL) procedures to climb from roughly 24.4 million globally in 2015 to nearly 30 million in 2020 at a compounded annual rate of 3.6 percent. Factors contributing to growth are an aging population, the availability of enhanced monofocal and premium-featured IOLs, robust demand for improved visual outcomes, and increasing worldwide access to advanced medical technology. The fastest growth is anticipated in developing countries and regions (China, India, and Latin America) with high population growth rates and relatively large population groups with cataracts that have not been surgically addressed.
We anticipate a number of enhancements to IOL designs during the next five years. These are likely to include more multifocal designs, a greater variety of toric optics, an increased number of multifocal and accommodating toric IOLs, and new accommodating IOLs with greater range.
We also look for improved aspheric and wavefront-designed IOLs, IOLs with postoperative adjustability, lenses with extended depth of focus (EDF or EDOF), optics that are free of glistening, improvements in injector technologies, including new preloaded disposable injectors, and new IOLs designed for even smaller incisions.
Other anticipated advances include more IOLs that filter visible blue light, phakic IOL enhancements, including toric optics and multifocal optics, combination IOLs that incorporate a number of the above technologies, add-on sulcus-fixated IOLs to improve postoperative outcomes for cataract patients, customized wavefront-designed IOLs, and IOLs designed to take full advantage of the precision of femtosecond laser cataract surgery.
These enhancements will expand the premium IOL segment, which by 2020 is expected to account for nearly 9.3 percent of total IOL procedures and almost 34 percent of total IOL market revenues.
The global IOL market is dominated by five companies, Alcon, Abbott Medical Optics, Bausch + Lomb, Hoya, and Carl Zeiss Meditec, each with unit sales exceeding 900 thousand. These five are expected to generate nearly three-quarters of global IOL revenues in 2015.
Market Scope published its 2015 Comprehensive Report on the Global IOL Market in June 2015. It is the only report that provides in-depth coverage of commercialized and investigational intraocular lenses used in treating cataracts. This report includes market data for 2014, and we forecast market performance through 2020. Our forecast also subdivides the IOL market into eight geographic/economic analytic categories: the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World.